143 related articles for article (PubMed ID: 12673182)
1. Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia.
Okada DR; Johnson G; Liu Z; Hocherman SD; Khaw BA; Pak KY; Okada RD
J Nucl Cardiol; 2003; 10(2):168-76. PubMed ID: 12673182
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-glucarate kinetics differentiate normal, stunned, hibernating, and nonviable myocardium in a perfused rat heart model.
Okada DR; Liu Z; Johnson G; Beju D; Khaw BA; Okada RD
Eur J Nucl Med Mol Imaging; 2010 Oct; 37(10):1909-17. PubMed ID: 20652807
[TBL] [Abstract][Full Text] [Related]
3. HL-91-technetium-99m: a new marker of viability in ischemic myocardium.
Okada RD; Johnson G; Nguyen KN; Carlson LR; Beju D
J Nucl Cardiol; 1999; 6(3):306-15. PubMed ID: 10385186
[TBL] [Abstract][Full Text] [Related]
4. Early detection of infarct in reperfused canine myocardium using 99mTc-glucarate.
Okada DR; Johnson G; Liu Z; Hocherman SD; Khaw BA; Okada RD
J Nucl Med; 2004 Apr; 45(4):655-64. PubMed ID: 15073263
[TBL] [Abstract][Full Text] [Related]
5. (99m)Tc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium.
Johnson G; Okada CC; Hocherman SD; Liu Z; Hart C; Khaw BA; Okada RD
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):319-28. PubMed ID: 16237571
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of myocardial ischemia and necrosis by technetium 99m glucaric acid kinetics.
Beanlands RS; Ruddy TD; Bielawski L; Johansen H
J Nucl Cardiol; 1997; 4(4):274-82. PubMed ID: 9278873
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m glucarate uptake in a swine model of limited flow plus increased demand.
Johnson LL; Schofield L; Mastrofrancesco P; Donahay T; Farb A; Khaw BA
J Nucl Cardiol; 2000; 7(6):590-8. PubMed ID: 11144474
[TBL] [Abstract][Full Text] [Related]
8. High-resolution imaging with (99m)Tc-glucarate for assessing myocardial injury in rat heart models exposed to different durations of ischemia with reperfusion.
Liu Z; Barrett HH; Stevenson GD; Kastis GA; Bettan M; Furenlid LR; Wilson DW; Pak KY
J Nucl Med; 2004 Jul; 45(7):1251-9. PubMed ID: 15235074
[TBL] [Abstract][Full Text] [Related]
9. Monocationic radiotracer kinetics and myocardial infarct size: a perfused rat heart study.
Okada DR; Liu Z; Beju D; Okada RD; Johnson G
Ann Nucl Med; 2008 Aug; 22(7):617-27. PubMed ID: 18756365
[TBL] [Abstract][Full Text] [Related]
10. Verapamil does not inhibit 99mTcN-NOET uptake in situ in normal or ischemic canine myocardium.
Riou LM; Ghezzi C; Vanzetto G; Broisat A; Mathieu JP; Bontron R; Pasqualini R; Fagret D
J Nucl Med; 2003 Jun; 44(6):981-7. PubMed ID: 12791829
[TBL] [Abstract][Full Text] [Related]
11. Detection of myocardial viability in ischemic-reperfused rat hearts by Tc-99m sestamibi kinetics.
Liu Z; Johnson G; Beju D; Okada RD
J Nucl Cardiol; 2001; 8(6):677-86. PubMed ID: 11725264
[TBL] [Abstract][Full Text] [Related]
12. Technetium 99m-Q12 kinetics in perfused rat myocardium: effects of hypoxia and low flow.
Okada RD; Nguyen KN; Lauinger M; Allton IL; Johnson G
Am Heart J; 1996 Jul; 132(1 Pt 1):108-15. PubMed ID: 8701850
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-sestamibi kinetics predict myocardial viability in a perfused rat heart model.
Liu Z; Okada DR; Johnson G; Hocherman SD; Beju D; Okada RD
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):570-8. PubMed ID: 17952434
[TBL] [Abstract][Full Text] [Related]
14. Myocardial kinetics of 99m technetium-Q agents: studies in isolated cardiac myocyte, isolated perfused rat heart, and canine regional myocardial ischemia models.
McGoron AJ; Biniakiewicz D; Millard RW; Kumar A; Kennedy SC; Roszell NJ; Gabel M; Huth C; Walsh RA; Gerson MC
Invest Radiol; 1999 Nov; 34(11):704-17. PubMed ID: 10548383
[TBL] [Abstract][Full Text] [Related]
15. Influence of calcium channel inhibitors on the myocardial uptake and retention of technetium 99m N-NOET, a new myocardial perfusion imaging agent: a study on isolated perfused rat hearts.
Riou L; Ghezzi C; Pasqualini R; Fagret D
J Nucl Cardiol; 2000; 7(4):365-72. PubMed ID: 10958279
[TBL] [Abstract][Full Text] [Related]
16. Clearance of technetium 99m N-NOET in normal, ischemic-reperfused, and membrane-disrupted myocardium.
Johnson G; Allton IL; Nguyen KN; Lauinger JM; Beju D; Pasqualini R; Duatti A; Okada RD
J Nucl Cardiol; 1996; 3(1):42-54. PubMed ID: 8799227
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-HL91. Effects of low flow and hypoxia on a new ischemia-avid myocardial imaging agent.
Okada RD; Johnson G; Nguyen KN; Edwards B; Archer CM; Kelly JD
Circulation; 1997 Apr; 95(7):1892-9. PubMed ID: 9107178
[TBL] [Abstract][Full Text] [Related]
18. Distribution of deoxyglucose and technetium-99m-glucarate in the acutely ischemic myocardium.
Yaoita H; Fischman AJ; Wilkinson R; Khaw BA; Juweid M; Strauss HW
J Nucl Med; 1993 Aug; 34(8):1303-8. PubMed ID: 8326389
[TBL] [Abstract][Full Text] [Related]
19. Effects of increased lipid concentration and hyperemic blood flow on the intrinsic myocardial washout kinetics of (99m)TcN-NOET.
Riou LM; Unger S; Toufektsian MC; Ruiz M; Watson DD; Beller GA; Glover DK
J Nucl Med; 2003 Jul; 44(7):1092-8. PubMed ID: 12843227
[TBL] [Abstract][Full Text] [Related]
20. Avidity of technetium 99m glucarate for the necrotic myocardium: in vivo and in vitro assessment.
Khaw BA; Nakazawa A; O'Donnell SM; Pak KY; Narula J
J Nucl Cardiol; 1997; 4(4):283-90. PubMed ID: 9278874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
